ABL Bio Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Sang Hoon Lee
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 8.8yrs |
| CEO ownership | 27.6% |
| Management average tenure | 2.8yrs |
| Board average tenure | no data |
Recent management updates
No updates
Recent updates
Some Confidence Is Lacking In ABL Bio Inc. (KOSDAQ:298380) As Shares Slide 30%
Nov 20
Is ABL Bio (KOSDAQ:298380) Using Too Much Debt?
May 29Is ABL Bio (KOSDAQ:298380) Weighed On By Its Debt Load?
Feb 26We Think ABL Bio (KOSDAQ:298380) Can Afford To Drive Business Growth
Mar 31Should ABL Bio (KOSDAQ:298380) Be Disappointed With Their 33% Profit?
Jan 20
Companies Like ABL Bio (KOSDAQ:298380) Are In A Position To Invest In Growth
Dec 16CEO
Sang Hoon Lee
8.8yrs
Tenure
Dr. Sang Hoon Lee, PH D co-founded PharmAbcine, Inc. in 2008 and serves as its Executive Vice President. Dr. Lee founded ABL Bio Inc. in February 2016 and serves as its President and Chief Executive Office...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 8.8yrs | no data | 27.56% ₩ 383.4b | |
| Executive VP | no data | no data | 1.55% ₩ 21.6b | |
| Executive VP & COO | no data | no data | no data | |
| Executive VP | 2.8yrs | no data | 1.43% ₩ 19.9b | |
| Executive VP & Chief of Discovery | no data | no data | no data | |
| Executive VP | no data | no data | no data | |
| Head of Medical & Clinical Development | 2.8yrs | no data | no data |
2.8yrs
Average Tenure
Experienced Management: A298380's management team is considered experienced (2.8 years average tenure).